NCT01654107

Persistence-Targeted Smoking Cessation

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 58 (actual)
• Sponsor: Rutgers, The State University of New Jersey · Academic / Other
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Accepted

Summary

The investigators propose to develop a theory-based smoking cessation intervention (called Persistence-targeted smoking cessation; PTSC). PTSC includes 8 weekly individual counseling sessions and use of nicotine lozenge for 12 weeks. The investigators will test the feasibility and preliminary efficacy of the intervention (i.e., cigarettes per day and prolonged abstinence).

Detailed description

In this Stage I Behavioral \& Integrative Treatment Development (R34) project, we propose to develop a theory-based smoking cessation intervention (called Persistence-targeted smoking cessation; PTSC). PTSC includes 8 weekly individual counseling sessions and use of nicotine lozenge for 12 weeks. We will test the feasibility and preliminary efficacy of the intervention (i.e., cigarettes per day and prolonged abstinence). We hope to develop a feasible psychosocial treatment for use in a later randomized controlled trial.

Conditions

• Tobacco Use Disorder

Interventions

Type	Name	Description
BEHAVIORAL	Persistence Targeted Smoking Cessation	8-weeks of smoking cessation counseling ("Persistence Targeted Smoking Cessation")
BEHAVIORAL	Clearing The Air	8-weeks counseling + 12-weeks nicotine lozenge based on NCI protocol, Clearing The Air
DRUG	Nicotine lozenge	12-weeks 4mg nicotine lozenge

Timeline

• Start date: 2012-07-01
• Primary completion: 2014-09-01
• Completion: 2014-09-01
• First posted: 2012-07-31
• Last updated: 2017-08-21
• Results posted: 2015-09-16

Locations

1 site across 1 country: United States